We are monitoring the impact of COVID-19 on Europe Point of Care (POC) Diagnostics/Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1482
Share on
Share on

Europe Point of Care (POC) Diagnostics/Testing Market Research Report – Segmented By Product, End-User, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1482
Pages: 175

Europe Point of Care (POC) Diagnostics/Testing Market Size (2021 to 2026)

The Point of Care (POC) Diagnostics/Testing Market in Europe was worth USD 6.98 billion in 2021. This value is further estimated to be growing at a CAGR of 9.72% from 2021 to 2026 and worth USD 11.10 billion by the end of 2026.

Sedentary lifestyles, bad eating habits, and environmental concerns are likely to boost the POC diagnostics market’s development rate. Furthermore, the growing need for efficient, easy-to-use, and faster consumer products and these portable personal care devices is expected to drive the European POC diagnostics market. 

In addition, the integration of automated techniques in healthcare is expected to increase the rise of new products launches of home testing cancer kits at regular intervals and enhanced laboratories. As a result, the key market players have created significant research and development activities to create innovative point of care tests and devices for rapid disease diagnosis and monitoring.

On the other hand, with the high prevalence of chronic diseases and cancers, a significant customer base uses low-cost, quick diagnostic tests, which drives the POC diagnostics market in the European region. Furthermore, the market is likely to accelerate as key companies increase their efforts to develop an enhanced point of care testing. Increased demand for efficient point-of-care diagnostics is boosted due to faster diagnostic outcomes than traditional procedures. In the coming years, the patient population and hospitalization are expected to generate lucrative economic prospects for the market.

One of the significant factors for the growth of the European point on care diagnostics market is the effort and coordination required among the healthcare centers, researchers, practitioners, and manufacturers. However, the point of care diagnostics market also faces problems such as industry resistance to modifying established norms, numerous product recalls, a strict regulatory environment, and an unfavorable reimbursement scenario.

This research report on the European POC diagnostics market has been segmented and sub-segmented into the following categories.

By Product:

  • Infectious Diseases
  • Cardiac Markers
  • Oncology Markers
  • OTC Diagnostic Tests
  • Drugs Of Abuse
  • Blood Gas Testing
  • Fertility Testing
  • Urinalysis
  • Coagulation
  • Hematology
  • Glucose Monitoring
  • Ambulatory Chemistry
  • Decentralized Clinical Chemistry

By End-User:

  • Clinics
  • Hospitals
  • Home Healthcare
  • Ambulatory Care Settings
  • Laboratories

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Europe is expected to command a decent share in the overall market in the next five years due to premium healthcare infrastructure, established reimbursement framework, and high healthcare affordability in this region. Moreover, the presence of high levels of awareness amongst the patient population base and the physicians associated with fast disease diagnosis is supportive in the industrial revenue.

The UK POC diagnostics market accounted for a significant share in the European market in 2020 and is predicted to grow at a prominent CAGR from 2021 to 2026.

The France POC diagnostics market is expected to play a significant role in the European POC diagnostics market during the forecast period due to the prevalence of unhealthy lifestyles, a high number of chronic diseases, and increased FDA approvals and government laws connected to healthcare development. In addition, France is one of the world’s most significant users of pharmaceutical products and one of the most complex to sell them.

The German POC diagnostics market is estimated to be growing at a promising CAGR during the forecast period. Increased government initiatives aimed at reducing hospital stays and improving healthcare infrastructure and favorable reimbursement policies are expected a rise the use of POC diagnostics in Europe.

KEY MARKET PLAYERS:

A few of the notable companies operating in the Europe Point of Care (POC) Diagnostics/Testing Market profiled in this report are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Infectious Diseases             

                                5.1.3 Cardiac Markers   

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests          

                                5.1.6 Drugs Of Abuse    

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing     

                                5.1.9 Urinalysis 

                                5.1.10 Coagulation         

                                5.1.11 Hematology         

                                5.1.12 Glucose Monitoring          

                                5.1.13 Ambulatory Chemistry    

                                5.1.14 Decentralized Clinical Chemistry 

                                5.1.15 Others   

                                5.1.16 Y-o-Y Growth Analysis, By Product              

                                5.1.17 Market Attractiveness Analysis, By Product            

                                5.1.18 Market Share Analysis, By Product             

                5.2 End-Users                   

                                5.2.1 Introduction           

                                5.2.2 Clinics        

                                5.2.3 Hospitals  

                                5.2.4 Home Healthcare 

                                5.2.5 Ambulatory Care Settings 

                                5.2.6 Laboratories           

                                5.2.7 Others      

                                5.2.8 Y-o-Y Growth Analysis, By End-Users           

                                5.2.9 Market Attractiveness Analysis, By End-Users          

                                5.2.10 Market Share Analysis, By End-Users        

                5.3 Mode of Delivery                     

                                5.3.1 Introduction           

                                5.3.2 OTC            

                                5.3.3 Prescription            

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery             

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery            

                                5.3.6 Market Share Analysis, By Mode of Delivery             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By End-Users

                                                6.1.3.4 By Mode of Delivery

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By End-Users

                                                6.1.4.4 By Mode of Delivery

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By End-Users

                                                6.1.5.4 By Mode of Delivery

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Roche Diagnostics                    

                8.4 BioMerieux                

                8.5 Siemens Healthcare                

                8.6 Beckman Coulter                     

                8.7 Becton Dickinson and Company                        

                8.8 Johnson & Johnson                 

                8.9 Johnson & Johnson                 

                8.10 PTS Diagnostics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  2. Europe Infectious Diseases Market By Region, From 2021 to 2026 (USD Billion)
  3. Europe Cardiac Markers Market By Region, From 2021 to 2026 (USD Billion)
  4. Europe Oncology Markers Market By Region, From 2021 to 2026 (USD Billion)
  5. Europe OTC Diagnostic Tests Market By Region, From 2021 to 2026 (USD Billion)
  6. Europe Drugs Of Abuse Market By Region, From 2021 to 2026 (USD Billion)
  7. Europe Blood Gas Testing Market By Region, From 2021 to 2026 (USD Billion)
  8. Europe Fertility Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. Europe Urinalysis Market By Region, From 2021 to 2026 (USD Billion)
  10. Europe Coagulation Market By Region, From 2021 to 2026 (USD Billion)
  11. Europe Hematology Market By Region, From 2021 to 2026 (USD Billion)
  12. Europe Glucose Monitoring Market By Region, From 2021 to 2026 (USD Billion)
  13. Europe Ambulatory Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  14. Europe Decentralized Clinical Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  15. Europe Others Market By Region, From 2021 to 2026 (USD Billion)
  16. Europe Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  17. Europe Clinics Market By Region, From 2021 to 2026 (USD Billion)
  18. Europe Hospitals Market By Region, From 2021 to 2026 (USD Billion)
  19. Europe Home Healthcare Market By Region, From 2021 to 2026 (USD Billion)
  20. Europe Ambulatory Care Settings Market By Region, From 2021 to 2026 (USD Billion)
  21. Europe Laboratories Market By Region, From 2021 to 2026 (USD Billion)
  22. Europe Others Market By Region, From 2021 to 2026 (USD Billion)
  23. Europe Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  24. Europe OTC Market By Region, From 2021 to 2026 (USD Billion)
  25. Europe Prescription Market By Region, From 2021 to 2026 (USD Billion)
  26. U.K. Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  27. U.K. Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  28. U.K. Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  29. Germany Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  30. Germany Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  31. Germany Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  32. France Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  33. France Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  34. France Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  35. Italy Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  36. Italy Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  37. Italy Point-of-Care Diagnostics Market By Mode of Delivery, From 2019 - 2024 ( USDGlobal Point of Care (POC Billion )
  38. Spain Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  39. Spain Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  40. Spain Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample